Dadu, Razvan T.
Ballantyne, Christie M.
Article History
First Online: 24 June 2014
Competing interests
: C.M.B. is a consultant for: Abbott, Aegerion, Amarin, Amgen, Arena, Cerenis, Esperion, Genentech, Genzyme, Kowa, Merck, Novartis, Omthera, Pfizer, Regeneron, Resverlogix, Roche, and Sanofi-Synthelabo; and a member of the speakers' bureau for Abbott. C.M.B.'s institution has received grants or research support from: Abbott, Amarin, Amgen, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, Regeneron, Roche, Sanofi-Synthelabo, and Takeda, and from the AHA and the NIH. R.T.D. declares no competing interests.